Correlation of Manual Screening and Automated (AutoPap 300) Analysis of Conventional Cervicovaginal Smears With HPV Typing Using Digene HC II Assay

Diagnostic Cytopathology

Volumn 29, Issue 5, 2003, Pages 256-261

  Walts, Ann E ^a   Thomas, Premi ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Automated screening; AutoPap 300 system; Cervicovaginal smear; Digene HPV hybrid capture (HC II); Human papillomavirus (HPV)

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; CANCER GRADING; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK FACTOR; SCREENING; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; VIRUS HYBRID; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 0242267969     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10382     Document Type: Article

References (18)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jensens AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869.
3. Barbosa MS. The oncogenic role of human papillomavirus proteins. Crit Rev Oncogen 1996;7:1-18.
4. Zur Hausen H. Human papillomaviruses. Cancer Res 1989;49:4677-4681.
5. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-1371.
6. Meijer CJLM, Snijders PJF, Brule A. Screening for cervical cancer: should we test for infection with high risk HPV? Can Med Assoc J 2000;163:535-538.
7. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening; a prospective study. Lancet 1999;354:20-25.
8. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ. The AutoPap System for primary screening in cervical cytology: comparing the results of a prospective, intended-use study with routine manual practice. Acta Cytol 1998;42:214-220.
9. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax Taylor D. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial. Cancer (Cancer Cytopathol) 1999;87:354-358.
10. Lee JS, Patten SF, Wilbur DC. The NeoPath AutoPap 300 System: utilization in primary screening for cervical cytology specimens. Pathol Res Pract 1997;193:436.
11. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Gabriel R, Quereux C, Birembaut P. Hybrid capture II based human papillomavirus detection, a sensitive test to detect in routine high grade cervical lesions: a preliminary study of 1518 women. Br J Cancer 1999;80:1306-1311.
12. Clavel C, Masure M, Levert M, Putaud I, Mangeonjean C, Lorenzato M, Mazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 2000;9:145-150.
13. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;291:1605-1610.
14. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934.
15. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Acta Cytol 1993;37:115-124.
16. Meijer CJ, Walboomers JM. Cervical cytology after 2000; where to go? J Clin Pathol 2000;53:41-43.
17. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
18. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.